Cargando…

FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma

BACKGROUND: Skin cutaneous melanoma is one of most aggressive type of cancers worldwide. Therefore, the identification of SKCM biomarkers is of great importance. FLG gene is one of the genes that encode proteins involved in epidermal formation. This was the first time to study the role of FLG in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Shaobo, Liang, Yuxia, Zang, Qijuan, Xing, Zixuan, Yin, Pan, Sun, Ruifang, Dai, Bingling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124147/ https://www.ncbi.nlm.nih.gov/pubmed/35607429 http://dx.doi.org/10.1155/2022/5160748

Ejemplares similares

The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM)
por: Wu, Shaobo, et al.
Publicado: (2021)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

Characterization of m6A-Related Genes Landscape in Skin Cutaneous Melanoma to Aid Immunotherapy and Assess Prognosis
por: Meng, Jinzhi, et al.
Publicado: (2021)

GATA3 regulates FLG and FLG2 expression in human primary keratinocytes
por: Zeitvogel, Jana, et al.
Publicado: (2017)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
por: Lin, Kefan, et al.
Publicado: (2023)

TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment
por: Zhu, Xinlin, et al.
Publicado: (2023)

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
por: Puglisi, Rossella, et al.
Publicado: (2021)

Straight and rigid flagellar hook made by insertion of the FlgG specific sequence into FlgE
por: Hiraoka, Koichi D., et al.
Publicado: (2017)

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers
por: Spiliopoulou, Pavlina, et al.
Publicado: (2023)

Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis
por: Neagu, Monica, et al.
Publicado: (2015)

m6A-Related lncRNAs Are Potential Biomarkers for the Prognosis of Metastatic Skin Cutaneous Melanoma
por: Huang, Suyang, et al.
Publicado: (2021)

The Identification of the Metabolism Subtypes of Skin Cutaneous Melanoma Associated With the Tumor Microenvironment and the Immunotherapy
por: Yang, Ronghua, et al.
Publicado: (2021)

Altered metabolomic states elicited by Flg22 and FlgII-28 in Solanum lycopersicum: intracellular perturbations and metabolite defenses
por: Zeiss, Dylan R., et al.
Publicado: (2021)

Anthropometry in the immunotherapy of cutaneous and ocular melanomas
por: Săftescu, Sorin, et al.
Publicado: (2020)

Cutaneous melanoma and the immunotherapy revolution (Review)
por: Leonardi, Giulia C., et al.
Publicado: (2020)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

Natural Variation for Responsiveness to flg22, flgII-28, and csp22 and Pseudomonas syringae pv. tomato in Heirloom Tomatoes
por: Veluchamy, Selvakumar, et al.
Publicado: (2014)

New Treatments for Atopic Dermatitis Targeting Skin Barrier Repair via the Regulation of FLG Expression
por: Dębińska, Anna
Publicado: (2021)

A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma
por: Xie, Yihui, et al.
Publicado: (2022)

Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
por: Li, Yang, et al.
Publicado: (2021)

PTPRC functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma
por: Li, Xuemei, et al.
Publicado: (2023)

A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
por: Song, Binyu, et al.
Publicado: (2022)

Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
por: Leng, Shaolong, et al.
Publicado: (2023)

Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)
por: Volovat, Simona Ruxandra, et al.
Publicado: (2021)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021)

Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients
por: Huang, Biao, et al.
Publicado: (2020)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022)

Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
por: Chun, Kyu-Hye, et al.
Publicado: (2023)

Immunotherapy for Non-melanoma Skin Cancer
por: Shalhout, Sophia Z., et al.
Publicado: (2021)

A Novel Pyroptosis-Related lncRNA Signature for Predicting the Prognosis of Skin Cutaneous Melanoma
por: Xie, Jiaheng, et al.
Publicado: (2021)

Pyroptosis-Related Gene Signatures Can Robustly Diagnose Skin Cutaneous Melanoma and Predict the Prognosis
por: Ju, Anji, et al.
Publicado: (2021)

CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
por: Yang, Jingrun, et al.
Publicado: (2022)

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017)

Significance of metastatic topography for the immunotherapy of cutaneous and ocular melanomas
por: Săftescu, Sorin, et al.
Publicado: (2020)

Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
por: Burzi, Lorenza, et al.
Publicado: (2021)

Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
por: Nikolaou, Vasiliki, et al.
Publicado: (2023)

FlgN Is Required for Flagellum-Based Motility by Bacillus subtilis
por: Cairns, Lynne S., et al.
Publicado: (2014)

How does SA signaling link the Flg22 responses?
por: Yi, So Young, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_85omcfnucb5b9lod5g1blloqrq